SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-078977
Filing Date
2020-06-30
Accepted
2020-06-30 16:14:52
Documents
3
Period of Report
2020-06-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023787d1_8k.htm 8-K 18323
2 EXHIBIT 99.1 tm2023787d1_ex99-1.htm EX-99.1 62180
3 GRAPHIC image_001.jpg GRAPHIC 4513
  Complete submission text file 0001104659-20-078977.txt   88086
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 201002483
SIC: 2834 Pharmaceutical Preparations